Evaluation of effectiveness of allergen subcutaneous immunotherapy in children with asthma
10.3760/cma.j.issn.1673-4408.2023.01.007
- VernacularTitle:儿童哮喘的变应原皮下免疫治疗有效性评价
- Author:
Yanan HAO
1
;
Changshan LIU
;
Xueyan WANG
Author Information
1. 天津医科大学第二医院儿科 300211
- Keywords:
Asthma;
Subcutaneous immunotherapy;
Evaluation;
Children
- From:
International Journal of Pediatrics
2023;50(1):34-37
- CountryChina
- Language:Chinese
-
Abstract:
Bronchial asthma(asthma)is a common chronic airway inflammatory disease in children, most of which are allergic asthma.Allergen immunotherapy can change the natural course of asthma, and has certain efficacy in controlling asthma symptoms, reducing airway hyperresponsiveness and reducing the use of control drugs.It is the treatment for the cause.The most common allergen immunotherapy treatments are subcutaneous immunotherapy and sublingual immunotherapy.This article reviews the effectiveness of subcutaneous immunotherapy in the treatment of children with asthma, and focuses on the effective evaluation indicators and potential biomarkers that can be used as reference in clinical practice.
